Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations
Clinical trial NCT01989546 · COMPLETED
Trial details
- NCT number
- NCT01989546
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-04
- Primary completion
- 2020-03-26
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.